{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:16:10Z","timestamp":1766268970787},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00198-012-2170-z","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T12:34:11Z","timestamp":1359376451000},"page":"1741-1749","source":"Crossref","is-referenced-by-count":38,"title":["Serotonin\u2013norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption"],"prefix":"10.1007","volume":"24","author":[{"given":"M. L. O.","family":"Shea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. D.","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Civitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"C. F.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J.","family":"Lenze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"key":"2170_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1001\/archgenpsychiatry.2009.81","volume":"66","author":"M Olfson","year":"2009","unstructured":"Olfson M, Marcus SC (2009) National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66:848\u2013856","journal-title":"Arch Gen Psychiatry"},{"key":"2170_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.amjopharm.2011.03.001","volume":"9","author":"SU Karkare","year":"2011","unstructured":"Karkare SU, Bhattacharjee S, Kamble P, Aparasu R (2011) Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother 9:109\u2013119","journal-title":"Am J Geriatr Pharmacother"},{"key":"2170_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.bone.2009.12.031","volume":"46","author":"SJ Warden","year":"2010","unstructured":"Warden SJ, Hassett SM, Bond JL et al (2010) Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels. Bone 46:985\u2013992","journal-title":"Bone"},{"key":"2170_CR4","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1097\/gme.0b013e318173566b","volume":"15","author":"SJ Warden","year":"2008","unstructured":"Warden SJ, Nelson IR, Fuchs RK, Bliziotes MM, Turner CH (2008) Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiency. Menopause 15:1176\u20131183","journal-title":"Menopause"},{"key":"2170_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.taap.2007.02.005","volume":"221","author":"N Bonnet","year":"2007","unstructured":"Bonnet N, Bernard P, Beaupied H, Bizot JC, Trovero F, Courteix D, Benhamou CL (2007) Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol 221:111\u2013118","journal-title":"Toxicol Appl Pharmacol"},{"key":"2170_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1210\/en.2004-1259","volume":"146","author":"SJ Warden","year":"2005","unstructured":"Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH (2005) Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146:685\u2013693","journal-title":"Endocrinology"},{"key":"2170_CR7","first-page":"121","volume":"8","author":"SJ Warden","year":"2008","unstructured":"Warden SJ, Haney EM (2008) Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies. J Musculoskelet Neuronal Interact 8:121\u2013132","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2170_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2009.06.029","volume":"46","author":"SJ Warden","year":"2010","unstructured":"Warden SJ, Robling AG, Haney EM, Turner CH, Bliziotes MM (2010) The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5). Bone 46:4\u201312","journal-title":"Bone"},{"key":"2170_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/jcb.21131","volume":"100","author":"R Battaglino","year":"2007","unstructured":"Battaglino R, Vokes M, Schulze-Spate U, Sharma A, Graves D, Kohler T, Muller R, Yoganathan S, Stashenko P (2007) Fluoxetine treatment increases trabecular bone formation in mice. J Cell Biochem 100:1387\u20131394","journal-title":"J Cell Biochem"},{"key":"2170_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/jcb.20734","volume":"98","author":"BI Gustafsson","year":"2006","unstructured":"Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, Slordahl K, Tamburstuen MV, Reseland JE, Syversen U (2006) Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 98:139\u2013151","journal-title":"J Cell Biochem"},{"key":"2170_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1096\/fj.07-9209com","volume":"22","author":"C Collet","year":"2008","unstructured":"Collet C, Schiltz C, Geoffroy V, Maroteaux L, Launay JM, de Vernejoul MC (2008) The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation. FASEB J 22:418\u2013427","journal-title":"FASEB J"},{"key":"2170_CR12","doi-asserted-by":"publisher","first-page":"16876","DOI":"10.1073\/pnas.0604234103","volume":"103","author":"R Yirmiya","year":"2006","unstructured":"Yirmiya R, Goshen I, Bajayo A, Kreisel T, Feldman S, Tam J, Trembovler V, Csernus V, Shohami E, Bab I (2006) Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci U S A 103:16876\u201316881","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2170_CR13","first-page":"133","volume":"8","author":"EM Haney","year":"2008","unstructured":"Haney EM, Warden SJ (2008) Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies. J Musculoskelet Neuronal Interact 8:133\u2013145","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2170_CR14","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","volume":"167","author":"EM Haney","year":"2007","unstructured":"Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, Barrett-Connor E, Orwoll E, Bliziotes MM (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167:1246\u20131251","journal-title":"Arch Intern Med"},{"key":"2170_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/archinte.167.2.188","volume":"167","author":"JB Richards","year":"2007","unstructured":"Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, Goltzman D (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167:188\u2013194","journal-title":"Arch Intern Med"},{"key":"2170_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","volume":"167","author":"SJ Diem","year":"2007","unstructured":"Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, Ensrud KE (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167:1240\u20131245","journal-title":"Arch Intern Med"},{"key":"2170_CR17","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00198-005-1866-8","volume":"16","author":"JA Cauley","year":"2005","unstructured":"Cauley JA, Fullman RL, Stone KL, Zmuda JM, Bauer DC, Barrett-Connor E, Ensrud K, Lau EM, Orwoll ES (2005) Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int 16:1525\u20131537","journal-title":"Osteoporos Int"},{"key":"2170_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/YIC.0b013e3282f2b3bb","volume":"23","author":"LJ Williams","year":"2008","unstructured":"Williams LJ, Henry MJ, Berk M, Dodd S, Jacka FN, Kotowicz MA, Nicholson GC, Pasco JA (2008) Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 23:84\u201387","journal-title":"Int Clin Psychopharmacol"},{"key":"2170_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/JCP.0b013e3182075587","volume":"31","author":"JM Bolton","year":"2011","unstructured":"Bolton JM, Targownik LE, Leung S, Sareen J, Leslie WD (2011) Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. J Clin Psychopharmacol 31:56\u201360","journal-title":"J Clin Psychopharmacol"},{"key":"2170_CR20","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/gerona\/63.12.1410","volume":"63","author":"B Mezuk","year":"2008","unstructured":"Mezuk B, Eaton WW, Golden SH, Wand G, Lee HB (2008) Depression, antidepressants, and bone mineral density in a population-based cohort. J Gerontol A Biol Sci Med Sci 63:1410\u20131415","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2170_CR21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJM199610173351602","volume":"335","author":"D Michelson","year":"1996","unstructured":"Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, Gold P (1996) Bone mineral density in women with depression. N Engl J Med 335:1176\u20131181","journal-title":"N Engl J Med"},{"key":"2170_CR22","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.amjmed.2005.07.033","volume":"118","author":"M Kinjo","year":"2005","unstructured":"Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118:1414","journal-title":"Am J Med"},{"key":"2170_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11606-008-0525-0","volume":"23","author":"L Spangler","year":"2008","unstructured":"Spangler L, Scholes D, Brunner RL, Robbins J, Reed SD, Newton KM, Melville JL, Lacroix AZ (2008) Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 23:567\u2013574","journal-title":"J Gen Intern Med"},{"key":"2170_CR24","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/archinte.163.8.949","volume":"163","author":"KE Ensrud","year":"2003","unstructured":"Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A, Hanlon JT, Nevitt MC, Whooley MA (2003) Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163:949\u2013957","journal-title":"Arch Intern Med"},{"key":"2170_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00223-011-9481-5","volume":"88","author":"SJ Diem","year":"2011","unstructured":"Diem SJ, Blackwell TL, Stone KL, Cauley JA, Hillier TA, Haney EM, Ensrud KE (2011) Use of antidepressant medications and risk of fracture in older women. Calcif Tissue Int 88:476\u2013484","journal-title":"Calcif Tissue Int"},{"key":"2170_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1359\/jbmr.061017","volume":"22","author":"CE Lewis","year":"2007","unstructured":"Lewis CE, Ewing SK, Taylor BC, Shikany JM, Fink HA, Ensrud KE, Barrett-Connor E, Cummings SR, Orwoll E (2007) Predictors of non-spine fracture in elderly men: the MrOS study. Research J Bone Miner Res Off J Am Soc Bone Miner Res 22:211\u2013219","journal-title":"Research J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"2170_CR27","doi-asserted-by":"crossref","unstructured":"Eom CS, Lee HK, Ye S, Park SM, Cho KH (2012) Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research","DOI":"10.1002\/jbmr.1554"},{"key":"2170_CR28","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1001\/archinte.167.21.2329","volume":"167","author":"F Eskandari","year":"2007","unstructured":"Eskandari F, Martinez PE, Torvik S et al (2007) Low bone mass in premenopausal women with depression. Arch Intern Med 167:2329\u20132336","journal-title":"Arch Intern Med"},{"key":"2170_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s00198-004-1730-2","volume":"16","author":"SY Wong","year":"2005","unstructured":"Wong SY, Lau EM, Lynn H, Leung PC, Woo J, Cummings SR, Orwoll E (2005) Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong). Osteoporos Int 16:610\u2013615","journal-title":"Osteoporos Int"},{"key":"2170_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/00042192-200512010-00015","volume":"12","author":"FN Jacka","year":"2005","unstructured":"Jacka FN, Pasco JA, Henry MJ, Kotowicz MA, Dodd S, Nicholson GC, Berk M (2005) Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study. Menopause 12:88\u201391","journal-title":"Menopause"},{"key":"2170_CR31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1532-5415.2001.49149.x","volume":"49","author":"J Robbins","year":"2001","unstructured":"Robbins J, Hirsch C, Whitmer R, Cauley J, Harris T (2001) The association of bone mineral density and depression in an older population. J Am Geriatr Soc 49:732\u2013736","journal-title":"J Am Geriatr Soc"},{"key":"2170_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0022-3999(98)00064-6","volume":"46","author":"R Coelho","year":"1999","unstructured":"Coelho R, Silva C, Maia A, Prata J, Barros H (1999) Bone mineral density and depression: a community study in women. J Psychosom Res 46:29\u201335","journal-title":"J Psychosom Res"},{"key":"2170_CR33","first-page":"140","volume":"34","author":"SL Silverman","year":"2007","unstructured":"Silverman SL, Shen W, Minshall ME, Xie S, Moses KH (2007) Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and\/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study. J Rheumatol 34:140\u2013144","journal-title":"J Rheumatol"},{"key":"2170_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/003335490512000112","volume":"120","author":"ME Mussolino","year":"2005","unstructured":"Mussolino ME (2005) Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep 120:71\u201375","journal-title":"Public Health Rep"},{"key":"2170_CR35","doi-asserted-by":"publisher","unstructured":"Diem SJ, Harrison SL, Haney E, Cauley JA, Stone KL, Orwoll E, Ensrud KE (2012) Depressive symptoms and rates of bone loss at the hip in older men. Osteoporos Int. doi:\n                    10.1007\/s00198-012-1975-0","DOI":"10.1007\/s00198-012-1975-0"},{"key":"2170_CR36","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4088\/JCP.v65n1208","volume":"65","author":"EM Whyte","year":"2004","unstructured":"Whyte EM, Basinski J, Farhi P, Dew MA, Begley A, Mulsant BH, Reynolds CF (2004) Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 65:1634\u20131641","journal-title":"J Clin Psychiatry"},{"key":"2170_CR37","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00198-008-0660-9","volume":"19","author":"P Szulc","year":"2008","unstructured":"Szulc P, Delmas PD (2008) Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int 19:1683\u20131704","journal-title":"Osteoporos Int"},{"key":"2170_CR38","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00198-009-0838-9","volume":"20","author":"R Civitelli","year":"2009","unstructured":"Civitelli R, Armamento-Villareal R, Napoli N (2009) Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int 20:843\u2013851","journal-title":"Osteoporos Int"},{"key":"2170_CR39","volume-title":"Structured clinical interview for DSM-IV axis i disorders (SCID), clinician version: administration booklet","author":"MB First","year":"1996","unstructured":"First MB, Spitzer RL, Gibbon M (1996) Structured clinical interview for DSM-IV axis i disorders (SCID), clinician version: administration booklet. Amer Psychiatric Pub Inc, Washington"},{"key":"2170_CR40","first-page":"382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry: J Ment Sci 134:382\u2013389","journal-title":"J Ment Sci"},{"key":"2170_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"issue":"Suppl 6","key":"2170_CR42","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1007\/s001980070004","volume":"11","author":"R Hannon","year":"2000","unstructured":"Hannon R, Eastell R (2000) Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int 11(Suppl 6):S30\u2013S44","journal-title":"Osteoporos Int"},{"key":"2170_CR43","doi-asserted-by":"crossref","unstructured":"Randolph C (1998) Repeatable battery for the assessment of neuropsychological status manual. The Psychological Corporation, San Antonio, TX","DOI":"10.1037\/t15149-000"},{"key":"2170_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","volume":"41","author":"MD Miller","year":"1992","unstructured":"Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF 3rd (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41:237\u2013248","journal-title":"Psychiatry Res"},{"key":"2170_CR45","first-page":"97","volume":"26","author":"MJ Seibel","year":"2005","unstructured":"Seibel MJ (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26:97\u2013122","journal-title":"Clin Biochem Rev"},{"key":"2170_CR46","unstructured":"O'Donnell JM, Shelton RC (2011) Drug Therapy of depression and anxiety disorders. In Laurence L. Brunton BAC, Bjorn C. Knollmann (ed) Goodman & Gilman's the pharmacological basis of therapeutics, 12th edition. McGraw-Hill, New York"},{"key":"2170_CR47","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1359\/JBMR.040606","volume":"19","author":"R Battaglino","year":"2004","unstructured":"Battaglino R, Fu J, Spate U, Ersoy U, Joe M, Sedaghat L, Stashenko P (2004) Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 19:1420\u20131431","journal-title":"J Bone Miner Res"},{"key":"2170_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1196\/annals.1296.011","volume":"1018","author":"OA Tjurmina","year":"2004","unstructured":"Tjurmina OA, Armando I, Saavedra JM, Li Q, Murphy DL (2004) Life-long serotonin reuptake deficiency results in complex alterations in adrenomedullary responses to stress. Ann N Y Acad Sci 1018:99\u2013104","journal-title":"Ann N Y Acad Sci"},{"key":"2170_CR49","doi-asserted-by":"crossref","unstructured":"Beluche I, Chaudieu I, Norton J, Carriere I, Boulenger JP, Ritchie K, Ancelin ML (2008) Persistence of abnormal cortisol levels in elderly persons after recovery from major depression. J Psychiatr Res","DOI":"10.1016\/j.jpsychires.2008.10.011"},{"key":"2170_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","volume":"18","author":"NM Simon","year":"2008","unstructured":"Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, Nierenberg AA, Fava M, Wong KK (2008) A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol 18:230\u2013233","journal-title":"Eur Neuropsychopharmacol"},{"key":"2170_CR51","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.jpsychires.2011.04.005","volume":"45","author":"H Aydin","year":"2011","unstructured":"Aydin H, Mutlu N, Akbas NB (2011) Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women. J Psychiatr Res 45:1316\u20131320","journal-title":"J Psychiatr Res"},{"key":"2170_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1192\/bjp.175.5.439","volume":"175","author":"KC Wilson","year":"1999","unstructured":"Wilson KC, Copeland JR, Taylor S, Donoghue J, McCracken CF (1999) Natural history of pharmacotherapy of older depressed community residents. The MRC-ALPHA Study. Br J Psychiatry 175:439\u2013443","journal-title":"Br J Psychiatry"},{"key":"2170_CR53","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.csda.2008.06.010","volume":"53","author":"AC Leon","year":"2009","unstructured":"Leon AC, Heo M (2009) Sample sizes required to detect interactions between two binary fixed-effects in a mixed-effects linear regression model. Comput Stat Data Anal 53:603\u2013608","journal-title":"Comput Stat Data Anal"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2170-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2170-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2170-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2170-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T03:20:16Z","timestamp":1581996016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-2170-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2170"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-2170-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}